Characterization of white matter hyperintensities in Down syndrome

White matter hyperintensities (WMH) are one of the imaging biomarkers of small vessel disease of presumed vascular origin. These lesions can be shown as areas of increases signal on fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging. WMH are frequently found in the elderly population and in both sporadic and genetic forms of Alzheimer’s disease (AD). … Read more

Microbleeds in individuals with Down Syndrome: Implications for Alzheimer’s disease treatment

Anti-amyloid drugs have emerged as a promising treatment for Alzheimer’s disease. However, these treatments can potentially cause cerebral microbleeds – small brain bleeds that may occur when amyloid is cleared from blood vessels. Understanding the natural history of these microbleeds is crucial for safe patient treatment and monitoring. This study, published in Neurology, provides key … Read more

Assessing the value of MRI for the diagnosis of tauopathies

MRI and tauopathies Progressive supranuclear palsy (PSP) and Corticobasal Degeneration (CBD) are two subtypes of Frontotemporal Lobular Degeneration characterized by cerebral accumulation of tau protein (tauopathies). These diseases present classically with motor symptoms that include postural instability, difficulty in ocular movements, and limb control. However, in recent years it has been shown that they can … Read more

Victor Montal defends his Doctoral Thesis

Víctor Montal Blancafort has presented today his Doctoral Thesis entitled “Complex neuroimaging changes in metabolite, cortical structures and regional vulnerabilities in the Alzheimer disease continuum“. The thesis, directed by Dr. Juan Fortea and supervised by Dr. Alberto Lleó, delves into new neuroimaging measures that help establishing the dynamic changes that occur throughout Alzheimer’s disease. Given … Read more

Jordi Pegueroles defends his Doctoral Thesis

Jordi Pegueroles - Sant Pau Memory Unit - Barcelona

In January 18th 2022, Jordi Pegueroles Monllau presented  his doctoral thesis entitled “The role of biomarkers in the current classification systems for Alzheimer’s Disease“. The thesis has been supervised by Dr. Juan Fortea and tutored by Dr. Alberto Lleó. This work has focused on the accuracy of different biomarkers of Alzheimer’s disease and their definition … Read more

What is the value of brain atrophy in frontotemporal dementia?

Atrophy - Illán-Gala - FTD - Sant Pau Memory Unit Barcelona

Atrophy and frontotemporal dementia The behavioral variant of frontotemporal dementia is a frequent cause of neurodegenerative dementia and the first cause of Frontotemporal Lobular Degeneration. Patients with the behavioral variant of frontotemporal dementia present a progressive personality change that begins years before diagnosis and can be confused with other neurodegenerative and psychiatric diseases. Identifying atrophy … Read more